← Back to Patent Explorer
US4783462A Expired / Lapsed US ⏱️ 0.0 years remaining

3(2H)pyridazinone, and anti-allergic agent containing it

Assignee: Nissan Chemical Corp
•
Filing: 1986-02-27
•
Granted: 1988-11-08
•
Expires: 2006-02-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A 3(2H)pyridazinone of the formula: ##STR1## wherein R 1 is hydrogen or C 1 -C 5 alkyl; R 2 is hydrogen, C 1 -C 8 alkyl, chlorine or bromine; A is --NR 3 -- or --O--; X is --(CH 2 ) n --, --CH(OR 4 )--, --CO-- or a single bond; when X is --(CH 2 ) n -- or a single bond, B is --O--, --S--, --NH--, --OSO 2 --, or --OCO-- or a single bond, when X is --CH(OR 4 )--, B is --O--, --S--, --NH-- or --OSO 2 --, and when X is --CO--, B is --O-- or --S--; and each of Y 1 , Y 2 and Y 3 which may be the same or different, is hydrogen, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, halogen, ##STR2## or two of Y 1 , Y 2 and Y 3 together form ##STR3## and a pharmaceutically acceptable salt thereof.

Inventors

  • 👤 Motoo Mutsukado
  • 👤 Keizo Tanikawa
  • 👤 Ken-ichi Shikada
  • 👤 Ryozo Sakoda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 00:34
CPC Classifications
C; C07; C07D; C07D403/00; C07D403/02; C07D403/12; A; A61; A61P; A61P11/00; A61P11/08; A61P27/00; A61P27/16; A61P37/00; A61P37/08; C07D237/00; C07D237/02; C07D237/06; C07D237/10; C07D237/14; C07D237/16; C07D237/22; C07D405/00; C07D405/02; C07D405/12

Claims Analysis

Total Claims: 30
Claim 1
Independent Claim 345 words
A 3(2H)pyridazinone of the formula: ##STR119## wherein R 1 is hydrogen or C 1 -C 5 alkyl; R 2 is hydrogen, C 1 -C 8 alkyl, chlorine or bromine; R 3 is hydrogen or C 1 - C 4 alkyl; X is --(CH 2 ) n --, wherein n is an integer of 1 to 4, --CH(OH 4 )--, wherein R 4 is hydrogen or C 1 -C 4 alkyl, --CO-- or a single bond; when X is --(CH 2 ) n --, wherein n is as defined above or a singel bond, B is --O--, --S--, --NH--, --OSO 2 --, or --OCO-- or a single bond; when X is --CH(OR 4 )--, wherein R 4 is as defined above, B is --O--, --S--, --NH-- or --OSO 2 --; and when X is --CO--, is --O-- or --S--; and each or Y 1 , Y 2 and Y 3 , which may be the same or different, is hydrogen, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, halogen, --OR 5 , wherein R 5 is hydrogen or C 1 -C 4 alkyl, --CO 2 R 6 , wherein R 6 is hydrogen or C 1 -C 4 alkyl, --CH═CHCO 2 R 7 , wherein R 7 is hydrogen or C 1 -C 4 alkyl, ##STR120## wherein each of R 8 an R 9 , which may be the same or different, is hydrogen or C 1 -C 4 alkyl, --COR 10 , wherein R 10 is hydrogen, C 1 -C 5 alkyl or ##STR121## with m being an integer of 0 to 3, R 11 being hydrogen or C 1 -C 3 alkyl, and R 12 being hydrogen or C 1 -C 4 alkyl, or any two, of Y 1 , Y 2 and Y 3 together forming ##STR122## wherein R 13 is hydrogen or C 1 -C 4 alkyl, provided that when R 3 is hydrogen and both X and B are single bonds, Y 1 , Y 2 and Y 3 are not simultaneously hydrogen, and a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 345 words
A 3(2H)pyridazinone of the formula: ##STR119## wherein R 1 is hydrogen or C 1 -C 5 alkyl; R 2 is hydrogen, C 1 -C 8 alkyl, chlorine or bromine; R 3 is hydrogen or C 1 - C 4 alkyl; X is --(CH 2 ) n --, wherein n is an integer of 1 to 4, --CH(OH 4 )--, wherein R 4 is hydrogen or C 1 -C 4 alkyl, --CO-- or a single bond; when X is --(CH 2 ) n --, wherein n is as defined above or a singel bond, B is --O--, --S--, --NH--, --OSO 2 --, or --OCO-- or a single bond; when X is --CH(OR 4 )--, wherein R 4 is as defined above, B is --O--, --S--, --NH-- or --OSO 2 --; and when X is --CO--, is --O-- or --S--; and each or Y 1 , Y 2 and Y 3 , which may be the same or different, is hydrogen, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, halogen, --OR 5 , wherein R 5 is hydrogen or C 1 -C 4 alkyl, --CO 2 R 6 , wherein R 6 is hydrogen or C 1 -C 4 alkyl, --CH═CHCO 2 R 7 , wherein R 7 is hydrogen or C 1 -C 4 alkyl, ##STR120## wherein each of R 8 an R 9 , which may be the same or different, is hydrogen or C 1 -C 4 alkyl, --COR 10 , wherein R 10 is hydrogen, C 1 -C 5 alkyl or ##STR121## with m being an integer of 0 to 3, R 11 being hydrogen or C 1 -C 3 alkyl, and R 12 being hydrogen or C 1 -C 4 alkyl, or any two, of Y 1 , Y 2 and Y 3 together forming ##STR122## wherein R 13 is hydrogen or C 1 -C 4 alkyl, provided that when R 3 is hydrogen and both X and B are single bonds, Y 1 , Y 2 and Y 3 are not simultaneously hydrogen, and a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 227 words
The pyridazinone according to claim 1, wherein R 2 is C 1 -C 8 alkyl, chlorine or bromine; when X is --(CH 2 ) n --, wherein n is an integer of 1 to 4 or a single bond, B is --O--, --S--, --OCO-- or a single bond; and when X is --CH(OR 4 ), wherein R 4 is hydrogen or C 1 -C 4 alkyl, or --CO--, B is --O-- or --S--; Y 1 is hydrogen; and each of Y 2 and Y 3 , which may be the same or different, is hydrogen, C 1 -C 8 alkyl, C 3 -C 8 alkenyl, halogen, --OR 5 , wherein R 5 is hydrogen or C 1 -C 4 alkyl, --CO 2 R 6 , wherein R 6 is hydrogen or C 1 -C 4 alkyl, --CH═CHCO 2 R 7 , wherein R 7 is hydrogen or C 1 -C 4 alkyl, ##STR123## --CON(R 8 )(R 9 ), wherein each of R 8 and R 9 , which may be the same or different, is hydrogen or C 1 -C 4 alkyl, --COR 10 , wherein R 10 is hydrogen, C 1 -C 5 alkyl or ##STR124## wherein m is an integer of 1 to 3, R 11 is hydrogen or C 1 -C 3 alkyl, and R 12 is hydrogen or C 1 -C 4 alkyl.
Claim 4
Dependent Claim 192 words
The pyridazinone according to claim 1, wherein R 1 is hydrogen or C 1 -C 4 alkyl; R 2 is C 1 -C 6 alkyl, chlorine or bromine; R 3 is hydrogen or methyl; X is --(CH 2 ) n --, wherein n is an integer of 1 to 3, --CH(OR 4 )--, wherein R 4 is hydrogen or C 1 -C 4 alkyl or --CO--; when X is --(CH 2 ) n , wherein n is as defined above, --CH(OR 4 )--, wherein R 4 is as defined above or --CO--, B is --O-- or --S--; Y 1 is hydrogen; and each of Y 2 and Y 3 , which may be the same or different, is hydrogen, C 1 -C 8 alkyl, C 3 -C 5 alkenyl, halogen, --OR 5 , wherein R 5 is hydrogen or C 1 -C 4 alkyl, --CO 2 R 6 , wherein R 6 is hydrogen or C.sub. 1 -C 4 alkyl, ##STR125## wherein R 10 is hydrogen, C 1 -C 5 alkyl or ##STR126## wherein R 11 is hydrogen or methyl, m is 0 to 1, and R 12 is hydrogen or methyl.
Claim 5
Dependent Claim 120 words
The pyridazinone according to claim 1, wherein R 1 is hydrogen or C 1 -C 4 alkyl; R 2 is C 1 -C 6 alkyl, chlorine or bromine; R 3 is hydrogen; X is --CH 2 --, --CH(OR 4 )--, wherein R 4 is hydrogen or methyl or --CO--; B is --O--; Y 1 is hydrogen; and each of Y 2 and Y 3 which may be the same or different, is C 1 -C 6 alkyl, C 3 - C 5 alkenyl, halogen, --OR 5 , wherein R 5 is hydrogen, methyl or ethyl, --CO 2 R 6 , wherein R 6 is hydrogen, methyl or ethyl, ##STR127## wherein R 7 is hydrogen or C 1 -C 5 alkyl.
Claim 6
Dependent Claim 103 words
The pyridazinone according to claim 1, wherein R 1 is hydrogen, ethyl or i-propyl; R 2 is C 1 -C 4 straight chain alkyl, chlorine or bromine; R 3 is hydrogen; X is --CH 2 --, --CH(OR 4 )--, wherein R 4 is hydrogen or methyl; B is --O--, Y 1 is hydrogen; and each of Y 2 and Y 3 , which may be the same or different, is C 2 -C 5 alkyl, alkyl, --OR 5 , wherein R 5 is hydrogen or methyl, --CO 2 R 6 , wherein R 6 is hydrogen or methyl, --CN, --CONH 2 or --CHO.
Claim 7
Dependent Claim 28 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-(2-n-propyl-4-ethoxycarbonylphenoxy)propylamino-2-i-propyl-3(2H) pyridazinone, 4-n-propyl-5-[3-(2-n-propyl-4-methoxycarbonylphenoxy)propylamino]-2-ethyl-3(2H)pyridazinone, 4-chloro-5-[3-(2-ethyl-4-formylphenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone, 4-chloro-5-[3-(2-ethyl-4-cyanophenoxy)propylamino-2-i-propyl-3(2H)pyridazinone, 4-chloro-5-[3-(2-ethyl-4-methoxycarbonylphenoxy)propylamino] -2-i-propyl-3(2H)pyridazinone, 4-chloro-5-[3-(2-n-propyl-4-methoxyphenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone, 4-chloro-5-[3-(2-ethyl-4-methoxyphenoxy)propylamino]-2-ethyl-3(2H)pyridazinone, 4-chloro-5-[3-(2-ethyl-4-methoxyphenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone, 4-chloro-5-[3-(2-n-propyl-4-hydroxyphenoxy)propylamino]-2-ethyl-3(2H)pyridazinone, 4-chloro-5-[3-(2-n-propyl-4-hydroxyphenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone, 4-bromo-5-[3-(2-n-propyl-4-methoxyphenoxy)propylamino]-2-ethyl-3(2H)pyridazinone, 4-bromo-5-[3-(2-ethyl-4-methoxyphenoxy)propylamino]-2-ethyl-3(2H)pyridazinone, methoxy-carbonylphenoxy)propyl-2-ethyl-3(2H)pyridazinone, 4-chloro-5-[3-(2-n-propyl-4-cyanopyhenoxy)propoxy]-2-ethyl-3(2H)pyridazinone, 4-n-butyl-5-[3-(2-n-propyl-4-methoxycarbonylphenoxy)propylamino]-3(2H)pyridazinone, 4-chloro-5-[2-methoxy-3-(2-n-propyl-4-cyanophenoxy)proyylamino]-2-i-propyl-3(2H)pyridazinone, or 4-chloro-5-[2-hydroxy-3-(2-n-propyl-4-cynophenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone.
Claim 8
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-(2-n-propyl-4-methoxycarbonylphenoxy)propylamino]-2-ethyl-3-(2H)pyridazinone.
Claim 9
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-(2-n-propyl-4-methoxycarbonylphenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone.
Claim 10
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-(2-n-propyl-4-carboxyphenoxy)propylamino]-2-i-propyl-3-(2H)pyridazinone.
Claim 11
Dependent Claim 10 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-(2-n propyl-4-carbamoylphenoxy)propylamino]-2-i-propyl-3-(2H)pyridazinone.
Claim 12
Dependent Claim 9 words
The pyrdazinone according to claim 1, which is 4-chloro-5-[3-(2-allyl-4-cyanophenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone.
Claim 13
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-(2-allyl-4-cyanophenoxy)propylamino]-2-ethyl-3(2H)pyridazinone.
Claim 14
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-(2-n-butyl-4-methoxycarbonylphenoxy)propylamino]-2-ethyl-3(2H)pyridazinone.
Claim 15
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-(2-n-butyl-4-carboxyphenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone.
Claim 16
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-(2-n-butyl-4-carboxyphenoxy)propylamino]-2-ethyl-3-(2H)pyridazinone.
Claim 17
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-2-n-butyl-4-carbamoylphenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone.
Claim 18
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-chloro-5-[3-2-n-butyl-4-carbamoylphenoxy)propylamino]-2ethyl-3(2H)pyridazinone.
Claim 19
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-bromo-5-[3-(2-n-propyl-4-cyanophenoxy)propylamino]-2-ethyl-3(2H)pyridazinone.
Claim 20
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-bromo-5-[3-(2-allyl-4-cyanophenoxy)propylamino]-2-2-ethyl--3(2H)pyridazinone.
Claim 21
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-bromo-5-[3-(2-n-propyl-4-methoxycarbonylphenoxy)propylamino]-2-ethyl-3(2H)pyridazinone.
Claim 22
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-bromo-5-[3-(2-n-propyl-4-carbamoylphenoxy)propylamino]-2-i-propyl-3(2H)pyidazinone.
Claim 23
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-bromo-5-[3-(2-allyl-4-cyanophenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone.
Claim 24
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-bromo-5-[3-(2-n-propyl-4-methoxycarbonylphenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone.
Claim 25
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-bromo-5-[3-(2-n-propyl-4-carboxyphenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone.
Claim 26
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-bromo-5-[3-(2-n-butyl-4-methoxycarbonylphenoxy)propylamino]-2-i-propyl-3(2H)pyridazinone.
Claim 27
Dependent Claim 9 words
The pyridazinone according to claim 1, which is 4-bromo-5-[3-(2-n-butyl-4-carboxyphenoxy)propylamino]-2-i-propyl-3-(2H)pyridazinone.
Claim 28
Dependent Claim 30 words
An anti-allergic agent, comprising: a pharmaceutically effective amount of a 3(2H)pyridazinone of formula 1 in claim 1 or a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier.
Claim 29
Dependent Claim 58 words
A method of reducing the incidence or severity of allergy induced in a subject by SRS-A, which comprises: administering to said subject an amount of the 3 (2H)pyridazinone as defined in claim 1 which is effective in reducing the incidence or severity of said allergy or a pharmaceutically acceptable salt thereof to a subject suffering from said allergy.
Claim 30
Dependent Claim 108 words
The method of claim 28, wherein the 3(2H)pyridazinone compound is of formula (I) wherein R 1 is hydrogen, ethyl or i-propyl; R 2 is C 1 -C 4 straight chain alkyl, chlorine or bromine; R 3 is hydrogen; X is --CH 2 --, --CH(OR 4 )--, wherein R 4 is hydrogen or methyl; B is --O--; Y 1 is hydrogen; and each of Y 2 and Y 3 , which may be the same or different, is C 2 -C 5 alkyl, allyl, --OR 5 , wherein R 5 is hydrogen or methyl, --COR 6 , wherein R 6 is hydrogen or methyl, --CN, --CONH 2 or --CHO.

References Cited (Backward Citations)

CA784639A Cited
GB917849A Cited
DE1670169A1 Cited
US4115575A Cited
US4558128A Cited
US4360672A Cited
SU1170970A3 Cited
EP0088384A1 Cited
EP0183212A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-11-08 1992-05-09 1992-11-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-11-08 1996-05-09 1996-11-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-11-08 2000-05-09 2000-11-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag